Literature DB >> 4829934

Demonstration and characterization of two distinct human leukocytic pyrogens.

C A Dinarello, N P Goldin, S M Wolff.   

Abstract

Human monocytes and neutrophils were separated from buffy coats of blood obtained from normal donors. Following incubation with heat-killed staphylococci, monocyte preparations contained 20 times more pyrogenic activity in the supernatant media than did supernates from an equal number of neutrophils. During purification of these pyrogens it was discovered that these cell preparations each produced a distinct and different pyrogen. The pyrogen obtained from neutrophils had a mol wt of 15,000 following Sephadex G-75 gel filtration, an isoelectric point of 6.9, and could be precipitated and recovered from 50% ethanol at -10 degrees C. In contrast, the pyrogen derived from monocyte preparations had a mol wt of 38,000, an isoelectric point of 5.1, and was destroyed in cold ethanol. Both molecules were unaffected by viral neuraminidase but biologically destroyed at 80 degrees C for 20 min and with trypsin at pH 8.0. The febrile peak produced by partially purified neutrophil pyrogen occurred at 40 min while that from monocytes was at 60 min. In addition, monocyte pyrogen produced more sustained fevers for the same peak elevation as neutrophil pyrogen. These studies demonstrate for the first time two chemically and biologically distinctive pyrogens derived from circulating human white blood cells and have important implications for our understanding of the pathogenesis of fever in man.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4829934      PMCID: PMC2139679          DOI: 10.1084/jem.139.6.1369

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

Review 1.  Fever.

Authors:  E Atkins; P Bodel
Journal:  N Engl J Med       Date:  1972-01-06       Impact factor: 91.245

2.  Factors affecting the quantitative production and assay of human leukocytic pyrogen.

Authors:  R K Root; J J Nordlund; S M Wolff
Journal:  J Lab Clin Med       Date:  1970-04

3.  Release of endogenous pyrogen by human monocytes.

Authors:  P Bodel; E Atkins
Journal:  N Engl J Med       Date:  1967-05-04       Impact factor: 91.245

4.  Human leukocyte pyrogen producing fever in rabbits.

Authors:  P Bodel; E Atkins
Journal:  Proc Soc Exp Biol Med       Date:  1966-03

5.  Studies on the mechanism of endogenous pyrogen production. I. Investigation of new protein synthesis in stimulated human blood leucocytes.

Authors:  P Bodel
Journal:  Yale J Biol Med       Date:  1970-12

6.  Comparison of endogenous pyrogens from human and rabbit leucocytes utilizing Sephadex filtration.

Authors:  P T Bodel; A Wechsler; E Atkins
Journal:  Yale J Biol Med       Date:  1969-04

7.  Synthesis of endogenous pyrogen by rabbit leukocytes.

Authors:  D M Moore; P A Murphy; P J Chesney; W B Wood
Journal:  J Exp Med       Date:  1973-05-01       Impact factor: 14.307

8.  Studies on the pathogenesis of fever. XIV. Further observations on the chemistry of leukocytic pyrogen.

Authors:  G W Rafter; S F Cheuk; D W Krause; W B Wood
Journal:  J Exp Med       Date:  1966-03-01       Impact factor: 14.307

9.  Studies on the origin of human leukocytic pyrogen.

Authors:  J J Nordlund; R K Root; S M Wolff
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307

10.  Pathogenetic mechanisms in experimental immune fever.

Authors:  R K Root; S M Wolff
Journal:  J Exp Med       Date:  1968-08-01       Impact factor: 14.307

View more
  70 in total

Review 1.  Interleukin 1α and the inflammatory process.

Authors:  Nelson C Di Paolo; Dmitry M Shayakhmetov
Journal:  Nat Immunol       Date:  2016-07-19       Impact factor: 25.606

Review 2.  Many cytokines are very useful therapeutic targets in disease.

Authors:  Marc Feldmann
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

Review 3.  The macrophage as a secretory cell in chronic inflammation.

Authors:  P Davies; A C Allison
Journal:  Agents Actions       Date:  1976-02

4.  Effects of a phagocytosis-stimulating factor derived from polymorphonuclear neutrophils on the functions of macrophages.

Authors:  Y Ishibashi; T Yamashita
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

5.  Human leukocytic pyrogen test for detection of pyrogenic material in growth hormone produced by recombinant Escherichia coli.

Authors:  C A Dinarello; J V O'Connor; G LoPreste; R L Swift
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

Review 6.  Therapy of autoinflammatory syndromes.

Authors:  Hal M Hoffman
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

Review 7.  Interleukin-1 function and role in rheumatic disease.

Authors:  Georg Schett; Jean-Michel Dayer; Bernhard Manger
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543

8.  Human leukocytic pyrogen induces release of specific granule contents from human neutrophils.

Authors:  M S Klempner; C A Dinarello; J I Gallin
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

9.  The macrophage in the development of experimental crescentic glomerulonephritis. Studies using tissue culture and electron microscopy.

Authors:  N M Thomson; S R Holdsworth; E F Glasgow; R C Atkins
Journal:  Am J Pathol       Date:  1979-02       Impact factor: 4.307

10.  Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.

Authors:  P E Auron; A C Webb; L J Rosenwasser; S F Mucci; A Rich; S M Wolff; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.